COMPANY TYPE DESCRIPTION PHASE DESCRIPTION
3P BIOPHARMACEUTICALS CRO / CMO GMP Cell Bank Manufacturing (MCB/WCB/EPCB) and storage 5RTM GMP Cell Bank Manufacturing (MCB/WCB/EPCB) and storage
Type: CRO / CMO
3P BIOPHARMACEUTICALS CRO / CMO GMP production (fermenters up to 1000L and Bioreactors up to 400L) for Clinical trials and Commercial stage 5RTM GMP production (fermenters up to 1000L and Bioreactors up to 400L) for Clinical trials and Commercial stage
Type: CRO / CMO
3P BIOPHARMACEUTICALS CRO / CMO Scale up and No GMP production for Preclinical studies 5RTM Scale up and No GMP production for Preclinical studies
Type: CRO / CMO
3P BIOPHARMACEUTICALS CRO / CMO Analytics development and validation platform (API, IMP, IPC) for Biosimilars 5RTM Analytics development and validation platform (API, IMP, IPC) for Biosimilars
Type: CRO / CMO
3P BIOPHARMACEUTICALS CRO / CMO Analytics development and validation platform (API, IMP, IPC) for New biological entities 5RTM Analytics development and validation platform (API, IMP, IPC) for New biological entities
Type: CRO / CMO
3P BIOPHARMACEUTICALS CRO / CMO Bioprocess Development/Optimization Platform (USP/DSP) 5RTM Bioprocess Development/Optimization Platform (USP/DSP)
Type: CRO / CMO
3P BIOPHARMACEUTICALS CRO / CMO Freedom-to-operate platform in Bacteria, yeast and mammalian 5RTM Freedom-to-operate platform in Bacteria, yeast and mammalian
Type: CRO / CMO
3P BIOPHARMACEUTICALS CRO / CMO Production of advanced Therapy Medicinal Products 5RTM Production of advanced Therapy Medicinal Products
Type: CRO / CMO
3P BIOPHARMACEUTICALS CRO / CMO API/IMP process development and GMP manufacturing 5RTM API/IMP process development and GMP manufacturing
Type: CRO / CMO
3P BIOPHARMACEUTICALS CRO / CMO Biologics production: New Biological Entities (mAbs, vaccines, fusion proteins) and Biosimilars/Biobetters from microbial fermentation and mammalian cell culture 5RTM Biologics production: New Biological Entities (mAbs, vaccines, fusion proteins) and Biosimilars/Biobetters from microbial fermentation and mammalian cell culture
Type: CRO / CMO
3P BIOPHARMACEUTICALS CRO / CMO Development of API formulation 5RTM Development of API formulation
Type: CRO / CMO
3P BIOPHARMACEUTICALS CRO / CMO Stability Studies (API/IMP/Cell banks) 5RTM Stability Studies (API/IMP/Cell banks)
Type: CRO / CMO
AC-Gen Reading Life Screening Phatogenomis 1R+D Phatogenomis
Type: Screening
AC-Gen Reading Life Screening Phatogenomics 5RTM Phatogenomics
Type: Screening
AC-Gen Reading Life Screening NGS, Sequence Capture; Genetic Diseases and Dysmorphic syndromes; Exome Analysis, Genomics, infections 5RTM NGS, Sequence Capture; Genetic Diseases and Dysmorphic syndromes; Exome Analysis, Genomics, infections
Type: Screening
ADM BIOPOLIS CRO / CMO Contract manufacturing: upstream and downstream development, analytical development, scale-up 5RTM Contract manufacturing: upstream and downstream development, analytical development, scale-up
Type: CRO / CMO
ADM BIOPOLIS CRO / CMO
Screening
Novel functional probiotics screening, validation and production 1R+D Novel functional probiotics screening, validation and production
Type: CRO / CMO
Screening
ADM BIOPOLIS CRO / CMO Metagenomics and metabolomic analysis 5RTM Metagenomics and metabolomic analysis
Type: CRO / CMO
ADM BIOPOLIS CRO / CMO Recombinant protein expression systems 1R+D Recombinant protein expression systems
Type: CRO / CMO
ADM BIOPOLIS CRO / CMO
Screening
Preclinical validation platforms: C.elegans model for functional food, ingredients and drug trials 5RTM Preclinical validation platforms: C.elegans model for functional food, ingredients and drug trials
Type: CRO / CMO
Screening
APTUS Biotech Drug Delivery
Enabling Technologies
Aptamer selection and characterization 5RTM Aptamer selection and characterization
Type: Drug Delivery
Enabling Technologies
Biobide CRO / CMO
Screening
Zebrafish Toxicity screening assays for Pharma, Biotech & Chemical candidate selection in early discovery and development phases: acute toxicity, developmental toxicity, neurotoxicity, cardiotoxicity, hepatotoxicity, ototoxicity, immunotoxicity, ecotox... 5RTM Zebrafish Toxicity screening assays for Pharma, Biotech & Chemical candidate selection in early discovery and development phases: acute toxicity, developmental toxicity, neurotoxicity, cardiotoxicity, hepatotoxicity, ototoxicity, immunotoxicity, ecotox...
Type: CRO / CMO
Screening
Biobide CRO / CMO
Screening
Zebrafish Efficacy Assays as well as target indentification and validation assays in different therapeutic areas for drug discovery: neurodegenerative diseases, oncology efficacy assays, immune response evaluation, infectious diseases, rare diseases... 5RTM Zebrafish Efficacy Assays as well as target indentification and validation assays in different therapeutic areas for drug discovery: neurodegenerative diseases, oncology efficacy assays, immune response evaluation, infectious diseases, rare diseases...
Type: CRO / CMO
Screening
Biobide CRO / CMO Zebrafish models generation for different therapeutic areas through morpholinos, transgenesis (Tol2 Kit), CRISPR/Cas9, TALENS, chemical induced models, xenograft models... 5RTM Zebrafish models generation for different therapeutic areas through morpholinos, transgenesis (Tol2 Kit), CRISPR/Cas9, TALENS, chemical induced models, xenograft models...
Type: CRO / CMO
Bionanoplus Drug Delivery MUCO-LAST Technology: Compositions for mucosal adhesion and uses thereof. Intelectual property rights until 2036 (PATENT: EP16382136). 3CV MUCO-LAST Technology: Compositions for mucosal adhesion and uses thereof. Intelectual property rights until 2036 (PATENT: EP16382136).
Type: Drug Delivery
Bionanoplus Drug Delivery Polymeric nanoemulsion technology for topical application 2PreV Polymeric nanoemulsion technology for topical application
Type: Drug Delivery
Bionanoplus Drug Delivery NANO-GES: drug delivery using polymeric encapsulation with esters of poly (methyl vinyl ether-co-maleic anhydride) PCT/EP2012/056900 4Reg. NANO-GES: drug delivery using polymeric encapsulation with esters of poly (methyl vinyl ether-co-maleic anhydride) PCT/EP2012/056900
Type: Drug Delivery
Bionanoplus Drug Delivery SANP: drug delivery using polimeric encapsulation with a vegetable hydrophobic protein PCT/EP2013/052795 3CV SANP: drug delivery using polimeric encapsulation with a vegetable hydrophobic protein PCT/EP2013/052795
Type: Drug Delivery
Bionanoplus Drug Delivery Antigen delivery for vaccines. Encapsulation of antigens with a polymer to increases the vaccination efficacy 2PreV Antigen delivery for vaccines. Encapsulation of antigens with a polymer to increases the vaccination efficacy
Type: Drug Delivery
Bionaturis CRO / CMO Development/manufacturing of active principles in a universally scalable technology in eukaryotes (FLYLIFE) 4Reg. Development/manufacturing of active principles in a universally scalable technology in eukaryotes (FLYLIFE)
Type: CRO / CMO
Bionaturis CRO / CMO
Screening
Biobide's platfom for Toxicity and Efficacy Assays of active compounds in Zebra Fish (validated and included in international regulations). Long track record of services to pharmas, agro-food, and cosmetic companies. Services include customised disease mo 5RTM Biobide's platfom for Toxicity and Efficacy Assays of active compounds in Zebra Fish (validated and included in international regulations). Long track record of services to pharmas, agro-food, and cosmetic companies. Services include customised disease mo
Type: CRO / CMO
Screening
Bionaturis Drug Delivery Zip's "Zera" platform for normalization of the immune response raised by recombinant vaccines, DNA/RNA vaccines. Elimination of cold-chain for storage by formation of metastable nanostructures comprising the antigen before delivery. 3CV Zip's "Zera" platform for normalization of the immune response raised by recombinant vaccines, DNA/RNA vaccines. Elimination of cold-chain for storage by formation of metastable nanostructures comprising the antigen before delivery.
Type: Drug Delivery
Bionos Biotech SL CRO / CMO
Screening
In vitro Cellular Models (HaCaT, NHDF, NHEK, NHEM, HFDPC, RHE, Eleutheroembryos, etc.). Efficacy and Toxicity Tests. Antioxidant and Detoxification (Lipid Peroxidation, Glycation, Carbonylation..), UV/IR/HEV Protection, DNA Repair, Cell Proliferation. 2PreV In vitro Cellular Models (HaCaT, NHDF, NHEK, NHEM, HFDPC, RHE, Eleutheroembryos, etc.). Efficacy and Toxicity Tests. Antioxidant and Detoxification (Lipid Peroxidation, Glycation, Carbonylation..), UV/IR/HEV Protection, DNA Repair, Cell Proliferation.
Type: CRO / CMO
Screening
CIBER/CIBER-BBN Enabling Technologies
Others
High Performance Computing. Integrated Infrastructure on Production and characterization of Nanomaterials, Biomaterials and systems in Biomedicine 1R+D High Performance Computing. Integrated Infrastructure on Production and characterization of Nanomaterials, Biomaterials and systems in Biomedicine
Type: Enabling Technologies
Others
CIBER/CIBER-BBN CRO / CMO
Enabling Technologies
Others
Production of Customized Biomaterials, Nanomaterials & Nanoconjugates 5RTM Production of Customized Biomaterials, Nanomaterials & Nanoconjugates
Type: CRO / CMO
Enabling Technologies
Others
CIBER/CIBER-BBN CRO / CMO
Enabling Technologies
Others
Production of Customized Biomolecules (Antibodies, Proteins and Peptides) 5RTM Production of Customized Biomolecules (Antibodies, Proteins and Peptides)
Type: CRO / CMO
Enabling Technologies
Others
CIBER/CIBER-BBN CRO / CMO
Enabling Technologies
Screening
Preclinical Validation-Bioimaging. Integrated Infrastructure on Production and characterization of Nanomaterials, Biomaterials and systems in Biomedicine 2PreV Preclinical Validation-Bioimaging. Integrated Infrastructure on Production and characterization of Nanomaterials, Biomaterials and systems in Biomedicine
Type: CRO / CMO
Enabling Technologies
Screening
CIBER/CIBER-BBN CRO / CMO
Enabling Technologies
Preclinical Validation-Tissue, Biomaterial and Surface Characterization 2PreV Preclinical Validation-Tissue, Biomaterial and Surface Characterization
Type: CRO / CMO
Enabling Technologies
ENTRECHEM Others Synthetic Biology for Human Health. Opening up the chemical space of complex bacterial natural products for oncology and immunosuppression applications 2PreV Synthetic Biology for Human Health. Opening up the chemical space of complex bacterial natural products for oncology and immunosuppression applications
Type: Others
Enzymlogic CRO / CMO
Screening
Development of an assay platform to perform binding kinetic profiling of GPCR agonist and antagonist in a HTS format 1R+D Development of an assay platform to perform binding kinetic profiling of GPCR agonist and antagonist in a HTS format
Type: CRO / CMO
Screening
Enzymlogic CRO / CMO
Screening
Development of an assay platform to perform binding kinetic profiling of KINASE inhibitors in a HTS format 1R+D Development of an assay platform to perform binding kinetic profiling of KINASE inhibitors in a HTS format
Type: CRO / CMO
Screening
FUND. PROGRESO Y SALUD CRO / CMO Maturing technological platform in advanced therapies: setting up and monitoring of clinical trials 3CV Maturing technological platform in advanced therapies: setting up and monitoring of clinical trials
Type: CRO / CMO
FUND. PROGRESO Y SALUD CRO / CMO
Screening
Andalusian's genomics and bioinformatic platform / Nanoimaging & Metabolomic platform / Biobank 5RTM Andalusian's genomics and bioinformatic platform / Nanoimaging & Metabolomic platform / Biobank
Type: CRO / CMO
Screening
FUND. PROGRESO Y SALUD CRO / CMO
Screening
Cancer Screening Cell lines & Animal Models 1R+D Cancer Screening Cell lines & Animal Models
Type: CRO / CMO
Screening
FUND. PROGRESO Y SALUD Screening Cell lines & Animal Models 2PreV Cell lines & Animal Models
Type: Screening
FUND. PROGRESO Y SALUD Enabling Technologies Hybridome/Antibody Production Platform 1R+D Hybridome/Antibody Production Platform
Type: Enabling Technologies
FUND. PROGRESO Y SALUD Drug Delivery Liposome delivery System (Prostate Cancer) 1R+D Liposome delivery System (Prostate Cancer)
Type: Drug Delivery
Fundacion MEDINA CRO / CMO Bioanalytical Platform 3CV Bioanalytical Platform
Type: CRO / CMO
Fundacion MEDINA Screening High throughput screening platform for drug discovery 3CV High throughput screening platform for drug discovery
Type: Screening
Fundacion MEDINA CRO / CMO Chemical Isolation & Structural Elucidation 3CV Chemical Isolation & Structural Elucidation
Type: CRO / CMO
Fundacion MEDINA CRO / CMO Microbial and Mammalian cell culturing 3CV Microbial and Mammalian cell culturing
Type: CRO / CMO
Fundacion MEDINA Screening High throughput screening platform for drug discovery 2PreV High throughput screening platform for drug discovery
Type: Screening
Fundacion MEDINA Screening Microbial Natural Product Libraries 3CV Microbial Natural Product Libraries
Type: Screening
Fundacion MEDINA Enabling Technologies
Screening
Mass spectrometry metabolomics 1R+D Mass spectrometry metabolomics
Type: Enabling Technologies
Screening
Fundacion MEDINA CRO / CMO Preclinical Safety Platform 3CV Preclinical Safety Platform
Type: CRO / CMO
Health in Code Screening Next Generation Sequencing by HiSeq 1500 5RTM Next Generation Sequencing by HiSeq 1500
Type: Screening
Histocell CRO / CMO Cell shipping medium. To develop ready-to-use cell based models for research 5RTM Cell shipping medium. To develop ready-to-use cell based models for research
Type: CRO / CMO
IIS La Fe Enabling Technologies Data Science, Biostatistics and Bioinformatics Unit: unsupervised analysis (clustering, PCA, SOM), analysis of omic data, simulation techniques (Monte Carlo) and resampling (Bootstrapping), R Programming, etc. 1R+D Data Science, Biostatistics and Bioinformatics Unit: unsupervised analysis (clustering, PCA, SOM), analysis of omic data, simulation techniques (Monte Carlo) and resampling (Bootstrapping), R Programming, etc.
Type: Enabling Technologies
IIS La Fe Screening Cytomics Unit: FACSAria-III cell sorter, FACSCanto-II flow cytometer and two high-content screening systems (Scan^R, Olympus, and InCell Analyzer, GE) 1R+D Cytomics Unit: FACSAria-III cell sorter, FACSCanto-II flow cytometer and two high-content screening systems (Scan^R, Olympus, and InCell Analyzer, GE)
Type: Screening
IIS La Fe Screening Genomic Unit: Next Generation Sequencing by Nexseq500 (Illumina), Ion PGM and Ion Proton. Arrays services by Affymetrix Platform 1R+D Genomic Unit: Next Generation Sequencing by Nexseq500 (Illumina), Ion PGM and Ion Proton. Arrays services by Affymetrix Platform
Type: Screening
IIS La Fe Enabling Technologies
Screening
Biotechnology platform: Expression and purification of recombinant proteins. Fragment-based screening 1R+D Biotechnology platform: Expression and purification of recombinant proteins. Fragment-based screening
Type: Enabling Technologies
Screening
IIS La Fe Screening Analytical Unit certified GLP: Targeted and untargeted metabolic studies by combination of chromatography and mass spectrometry techniques 3CV Analytical Unit certified GLP: Targeted and untargeted metabolic studies by combination of chromatography and mass spectrometry techniques
Type: Screening
IIS La Fe Enabling Technologies Experimental Radiology and Imaging Biomarkers Platform: MR imaging acquisition, image acquisition US, angiographic studies and processing by large and small animal imaging (3 Tesla Magnetic Resonance Unit,etc.) 1R+D Experimental Radiology and Imaging Biomarkers Platform: MR imaging acquisition, image acquisition US, angiographic studies and processing by large and small animal imaging (3 Tesla Magnetic Resonance Unit,etc.)
Type: Enabling Technologies
IIS La Fe Others Epigenomics Unit: DNA methylation and histone modifications at a genomic scale. High-performance technologies based on arrays of methylation and chromatin immunoprecipitation (ChIP) analysis. Any kind of samples (FFPE and frozen tumour). 2PreV Epigenomics Unit: DNA methylation and histone modifications at a genomic scale. High-performance technologies based on arrays of methylation and chromatin immunoprecipitation (ChIP) analysis. Any kind of samples (FFPE and frozen tumour).
Type: Others
IIS La Fe Enabling Technologies Platform for Health ICT: Big Data and Digital Health.Treatment of large amounts of data (RWD) and development of methodologies and tools to support clinical decisions 2PreV Platform for Health ICT: Big Data and Digital Health.Treatment of large amounts of data (RWD) and development of methodologies and tools to support clinical decisions
Type: Enabling Technologies
IMMUNOSTEP Enabling Technologies Reagents, columns and devices for Cell separation in Blood and Lymphatic systems 2PreV Reagents, columns and devices for Cell separation in Blood and Lymphatic systems
Type: Enabling Technologies
InKemia IUCT group CRO / CMO Drug development platform: GMP Manufacturing of investigational drugs; Production of solid, semisolid and liquid (non-sterile) pharmaceutical products, Production of medicinal products under research and veterinary medicinal products. 1R+D Drug development platform: GMP Manufacturing of investigational drugs; Production of solid, semisolid and liquid (non-sterile) pharmaceutical products, Production of medicinal products under research and veterinary medicinal products.
Type: CRO / CMO
InKemia IUCT group CRO / CMO Drug development platform: Stability studies under ICH conditions (Product storage according to ICH regulations, Product testing, Development of study protocol, Preparation for the study report) 1R+D Drug development platform: Stability studies under ICH conditions (Product storage according to ICH regulations, Product testing, Development of study protocol, Preparation for the study report)
Type: CRO / CMO
InKemia IUCT group CRO / CMO Drug development platform: Galenic development (Pre-formulation studies , Formulations development, Formulations Optimization, Stability Formulations, Comparison of dissolution profiles, Batch Productions at pilot levels, Support in technological transfer 1R+D Drug development platform: Galenic development (Pre-formulation studies , Formulations development, Formulations Optimization, Stability Formulations, Comparison of dissolution profiles, Batch Productions at pilot levels, Support in technological transfer
Type: CRO / CMO
Integromics Screening Genomics Analysis for Personalized Medicine/Diagnosis 1R+D Genomics Analysis for Personalized Medicine/Diagnosis
Type: Screening
Iproteos Enabling Technologies
Screening
IPROTech is a proprietary platform for the discovery and development of peptidomimetics able to disrupt and/or modulate intracellular protein-protein interactions (PPI). Iproteos applies IPROTech both to internal pipeline and to partnership projects. 5RTM IPROTech is a proprietary platform for the discovery and development of peptidomimetics able to disrupt and/or modulate intracellular protein-protein interactions (PPI). Iproteos applies IPROTech both to internal pipeline and to partnership projects.
Type: Enabling Technologies
Screening
IRYCIS Others
Screening
miRNA platform to collaborate in the development and commercialization of new biomarkers for diagnosis, prognosis and drug response 3CV miRNA platform to collaborate in the development and commercialization of new biomarkers for diagnosis, prognosis and drug response
Type: Others
Screening
Leitat CRO / CMO
Enabling Technologies
Screening
SKIN HEALTH & COSMETICS: Safety Beauty Dermatology 3CV SKIN HEALTH & COSMETICS: Safety Beauty Dermatology
Type: CRO / CMO
Enabling Technologies
Screening
Leitat CRO / CMO
Drug Delivery
Enabling Technologies
Screening
ONCOLOGY & ANGIOGENESIS: Target discovery, Drug Efficacy, Drug development 3CV ONCOLOGY & ANGIOGENESIS: Target discovery, Drug Efficacy, Drug development
Type: CRO / CMO
Drug Delivery
Enabling Technologies
Screening
Leitat CRO / CMO
Drug Delivery
Enabling Technologies
Screening
DIAGNOSIS & BIOSENSORS: Biomarkers, Theragnostics, Remote sensing 3CV DIAGNOSIS & BIOSENSORS: Biomarkers, Theragnostics, Remote sensing
Type: CRO / CMO
Drug Delivery
Enabling Technologies
Screening
Leitat CRO / CMO
Drug Delivery
Enabling Technologies
METABOLOMICS & BIOANALYTICS: Mass spectrometry, Chromatography, Bioinformatics 3CV METABOLOMICS & BIOANALYTICS: Mass spectrometry, Chromatography, Bioinformatics
Type: CRO / CMO
Drug Delivery
Enabling Technologies
Leitat CRO / CMO
Drug Delivery
Enabling Technologies
Screening
NUTRITION & FOOD SCIENCES: Body barriers (skin, digestive,,,), ADMEtox, Energetic metabolism, Microbiota 3CV NUTRITION & FOOD SCIENCES: Body barriers (skin, digestive,,,), ADMEtox, Energetic metabolism, Microbiota
Type: CRO / CMO
Drug Delivery
Enabling Technologies
Screening
Leitat CRO / CMO
Enabling Technologies
Screening
In vivo animal model platform (Oncology, Angiogenesis, Efficacy, pre-Tox, Biodistribution, pre-Pk, Drug Reprofiling, humanised pseudogerm-free murine models) Syngenic & xenogenic, Subcutaneous & orthotopic, Experimental & spontaneous metastasis, Patient 5RTM In vivo animal model platform (Oncology, Angiogenesis, Efficacy, pre-Tox, Biodistribution, pre-Pk, Drug Reprofiling, humanised pseudogerm-free murine models) Syngenic & xenogenic, Subcutaneous & orthotopic, Experimental & spontaneous metastasis, Patient
Type: CRO / CMO
Enabling Technologies
Screening
Leitat CRO / CMO
Drug Delivery
Enabling Technologies
Screening
REGENERATIVE MEDICINE: Pharmacology, In vivo imaging, Stem cell therapy, Sports medicine, Muscle and tendon in vivo models 3CV REGENERATIVE MEDICINE: Pharmacology, In vivo imaging, Stem cell therapy, Sports medicine, Muscle and tendon in vivo models
Type: CRO / CMO
Drug Delivery
Enabling Technologies
Screening
Leitat CRO / CMO
Drug Delivery
Enabling Technologies
Screening
In vitro cellular models platform (Efficacy, pre-Tox, Mechanism of Action, Drug Reprofiling). Studies of proliferation, viability, apoptosis, migration, invasion, wound healing, adhesion, and many others in monolayer cell cultures of primary cells (endot 5RTM In vitro cellular models platform (Efficacy, pre-Tox, Mechanism of Action, Drug Reprofiling). Studies of proliferation, viability, apoptosis, migration, invasion, wound healing, adhesion, and many others in monolayer cell cultures of primary cells (endot
Type: CRO / CMO
Drug Delivery
Enabling Technologies
Screening
Leitat CRO / CMO
Drug Delivery
Enabling Technologies
Screening
Polyclonal & Monoclonal Antibody Generation and Production Platform. Recombinant proteins, Immunization, Serum title, Mouse polyclonals, Fusion, Screening, Cloning, Hybridomas, Isotyping, Production & Purification, F(ab’)2, Fab, scFv, Conjugation, ELIS 5RTM Polyclonal & Monoclonal Antibody Generation and Production Platform. Recombinant proteins, Immunization, Serum title, Mouse polyclonals, Fusion, Screening, Cloning, Hybridomas, Isotyping, Production & Purification, F(ab’)2, Fab, scFv, Conjugation, ELIS
Type: CRO / CMO
Drug Delivery
Enabling Technologies
Screening
Leitat CRO / CMO
Enabling Technologies
Screening
Antibody & Protein Engineering Platform: Cloning, Chimeric mAbs, Humanized mAbs, scFv fragments, Fusion proteins Modeling, Transient expression, Stable clones, Nanobodies, Bispecifics, ADCs, Production, Biosimilars 5RTM Antibody & Protein Engineering Platform: Cloning, Chimeric mAbs, Humanized mAbs, scFv fragments, Fusion proteins Modeling, Transient expression, Stable clones, Nanobodies, Bispecifics, ADCs, Production, Biosimilars
Type: CRO / CMO
Enabling Technologies
Screening
Lipopharma Therapeutics Enabling Technologies Membrane-Lipid Therapy (MLT), a novel therapeutic approach targeting lipid metabolism 3CV Membrane-Lipid Therapy (MLT), a novel therapeutic approach targeting lipid metabolism
Type: Enabling Technologies
Minoryx Enabling Technologies SEE-Tx: Site-directed Enzyme Enhancement Therapy 2PreV SEE-Tx: Site-directed Enzyme Enhancement Therapy
Type: Enabling Technologies
OPERON Screening Opegen S.pneumoniae: Molecular test for the genotyping of Streptococcus pneumoniae infections 3CV Opegen S.pneumoniae: Molecular test for the genotyping of Streptococcus pneumoniae infections
Type: Screening
OWL Metabolomics CRO / CMO OWL Skin: Dermatitis and other skin diseases 5RTM OWL Skin: Dermatitis and other skin diseases
Type: CRO / CMO
StemTek Therapeutics Screening Drug screening / Discovery / validation on cancer stem cells, phenotypic HTS screening, secondary validation to in vivo efficacy testing 5RTM Drug screening / Discovery / validation on cancer stem cells, phenotypic HTS screening, secondary validation to in vivo efficacy testing
Type: Screening
VIVEBIOTECH CRO / CMO Development of more cost-effective gene therapy processes 3CV Development of more cost-effective gene therapy processes
Type: CRO / CMO
VIVEBIOTECH CRO / CMO LENTISOMA platform: for the R&D manufacture of lentiviral vectors with an enhanced safety profile. 3CV LENTISOMA platform: for the R&D manufacture of lentiviral vectors with an enhanced safety profile.
Type: CRO / CMO
Vivia Biotech CRO / CMO
Enabling Technologies
Screening
Cytometry Analysis for Personalized Medicine/Diagnosis/Pharma Profiling. Drug profiling and biomarker discovery collaborations 5RTM Cytometry Analysis for Personalized Medicine/Diagnosis/Pharma Profiling. Drug profiling and biomarker discovery collaborations
Type: CRO / CMO
Enabling Technologies
Screening
Vytrus Biotech CRO / CMO Development and manufacturing of recombinant proteins through the technology of plant cell cultures 1R+D Development and manufacturing of recombinant proteins through the technology of plant cell cultures
Type: CRO / CMO
ZeClinics CRO / CMO
Screening
Discovery-preclinical safety services for drug discovery using zebrafish. ZeTox: acute, chronic, general and organ-specific toxicology tests. 5RTM Discovery-preclinical safety services for drug discovery using zebrafish. ZeTox: acute, chronic, general and organ-specific toxicology tests.
Type: CRO / CMO
Screening
ZeClinics CRO / CMO
Enabling Technologies
Screening
Discovery-preclinical disease modeling services using zebrafish. ZeGenesis: generation of knock-out, knock-in, transgenics zebrafish or cell lines through CRISPR/Cas9. 5RTM Discovery-preclinical disease modeling services using zebrafish. ZeGenesis: generation of knock-out, knock-in, transgenics zebrafish or cell lines through CRISPR/Cas9.
Type: CRO / CMO
Enabling Technologies
Screening
ZeClinics CRO / CMO
Enabling Technologies
Screening
Discovery-preclinical services for drug efficacy using zebrafish. ZeEfficacy: early bioactivity evaluation of compound libraries with high-content phenotypical screenings. 5RTM Discovery-preclinical services for drug efficacy using zebrafish. ZeEfficacy: early bioactivity evaluation of compound libraries with high-content phenotypical screenings.
Type: CRO / CMO
Enabling Technologies
Screening